ICPT Historical Earnings image   This ICPT historical earnings page last updated 5/9/2022
ICPT Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20225/6/20220.09B
Q4 20213/2/20220.09B
Q3 202111/3/20210.09B
Q2 20217/29/20210.10B
Q1 20215/6/20210.08B
Q4 20202/25/20210.08B
Q3 202011/9/20200.08B
Q2 20208/10/20200.08B
Q1 20205/11/20200.07B
Q4 20192/25/20200.07B
Q3 201911/5/20190.06B
Q2 20198/7/20190.07B
Q1 20195/8/20190.05B
Q4 20182/28/201953.28M
Q3 201810/31/201846.99M
Q2 20188/2/201843.58M
Q1 20185/8/201835.96M
Q4 20172/14/201837.69M
Q3 201711/1/201741.33M
Q2 20177/31/201730.89M
Q1 20175/4/201721.05M
Q4 20162/23/201713.81M
Q3 201611/3/20165.18M
Q2 20168/4/20165.52M
Q1 20165/5/2016445000
Q4 20152/25/2016447000
Q3 201511/9/2015445000
Q2 20158/5/2015445000
Q1 20155/11/20151.45M
Q4 20143/2/2015445000
Q3 201411/7/2014445000
Q2 20148/11/2014445000
Q1 20145/7/2014405000
Q4 20133/14/2014405000
Q3 201311/14/2013405407
Q2 20138/13/2013405000
Q1 20135/14/20130.00B
Q4 20123/18/20130.00B
Q3 201211/5/2012523191
ICPT Historical Earnings EPS
Data adjusted for ICPT split history

PeriodHistorical Earnings DateGAAP
Q1 20225/6/2022-0.580
Q4 20213/2/2022-1.230
Q3 202111/3/2021-0.630
Q2 20217/29/2021-0.330
Q1 20215/6/2021-1.220
Q4 20202/25/2021-1.580
Q3 202011/9/2020-1.610
Q2 20208/10/2020-1.920
Q1 20205/11/2020-2.860
Q4 20192/25/2020-2.990
Q3 201911/5/2019-2.590
Q2 20198/7/2019-2.280
Q1 20195/8/2019-3.030
Q4 20182/28/2019-2.97
Q3 201810/31/2018-2.18
Q2 20188/2/2018-2.58
Q1 20185/8/2018-3.22
Q4 20172/14/2018-4.43
Q3 201711/1/2017-2.89
Q2 20177/31/2017-3.46
Q1 20175/4/2017-3.61
Q4 20162/23/2017-4.84
Q3 201611/3/2016-3.59
Q2 20168/4/2016-3.14
Q1 20165/5/2016-5.17
Q4 20152/25/2016-3.62
Q3 201511/9/2015-2.1
Q2 20158/5/2015-1.99
Q1 20155/11/2015-1.78
Q4 20143/2/2015-1.63
Q3 201411/7/2014-1.69
Q2 20148/11/20141.51
Q1 20145/7/2014-13.21
Q4 20133/14/2014-0.64
Q3 201311/14/2013-1.74
Q2 20138/13/2013-0.79
Q1 20135/14/2013-0.62
Q4 20123/18/2013-2.02
Q3 201211/5/2012-1.86
Quotes delayed 20 minutes

Email EnvelopeFree ICPT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Intercept Pharmaceuticals (ICPT) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ICUI Past Earnings
ICVX Past Earnings
IDRA Past Earnings
IDXX Past Earnings
IDYA Past Earnings
IGMS Past Earnings
IIN Past Earnings
IKNA Past Earnings
IKT Past Earnings
ILMN Past Earnings
What was the record high ICPT historical earnings result?
In terms of earnings or revenue, what is the best ICPT historical earnings result that Intercept Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest ICPT historical earnings result was set in Q2 2014, when Intercept Pharmaceuticals posted results of 1.51/share. The most successful revenue quarter within our data set was Q2 2021 when Intercept Pharmaceuticals reported revenue of 0.10B.

What was the lowest Intercept Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest ICPT has reported, and when?

✔️Accepted answer: Within our data set, the lowest ICPT historical earnings result was set in Q1 2014, when Intercept Pharmaceuticals posted results of -13.21/share. The smallest revenue quarter within our data set was Q1 2014 when Intercept Pharmaceuticals reported revenue of 405000.

On this page we presented the ICPT historical earnings date information for Intercept Pharmaceuticals. Reviewing that ICPT Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2014, when ICPT posted gaap of 1.51/share. Meanwhile the lowest ICPT historical earnings result was in Q1 2014, when ICPT posted gaap of -13.21/share. Moving to Intercept Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2021 when ICPT reported 0.10B in revenue, while the smallest revenue quarter was Q1 2014 when ICPT reported 405000 in revenue.

For self directed investors doing their due diligence on ICPT or any other given stock, their research can benefit from looking into all of the Intercept Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Intercept Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for ICPT. Thanks for visiting, and the next time you need to research ICPT historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: SPTN Options Chain, Mohawk Industries DMA, VEU YTD Return.

 

ICPT Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.